ABCB4 and sclerosing cholangitis: In support of our findings here, a study using a Mdr2(−/−) mouse model, displaying blockade of β-adrenoceptors has been shown to be a promising therapeutic strategy in the treatment of human primary sclerosing cholangitis [34].